Brief: Titan Pharmaceuticals Fully Compliant With Nasdaq Listing Criteria
25/01/2024 22:33
Titan Pharmaceuticals Inc TTNP.O :
* TITAN PHARMACEUTICALS FULLY COMPLIANT WITH NASDAQ LISTING
CRITERIA
Source text for Eikon: ID:nGNXbX4PJN
Further company coverage: TTNP.O
Recent news on Titan Pharmaceuticals
See all newsBrief: Titan Pharmaceuticals Announces $1 Million Private Placement Of Convertible Preferred Stock
Brief: Titan Pharmaceuticals- Appoints Brynner Chiam As Acting Principal Executive Officer & Acting Principal Financial Officer Of Co
U.S. STOCKS ON THE MOVE-Newmont, Monopar Therapeutics, TKO Group
Titan Pharma falls as CEO announces resignation
Brief: Titan Pharmaceuticals Enters Into Merger Agreement With Ke Sdn. Bhd.